Adalvo Ltd. Pharmadox Healthcare Limited
PolandAll drugs from this manufacturer
-
The medicine is used in adults with active psoriatic arthritis, chronic plaque psoriasis (moderate to severe), and Behçet's disease (for the treatment of oral ulcers).
Dosage form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC: L04AA32
-
The medicine is used in adults with active psoriatic arthritis, chronic plaque psoriasis (moderate to severe), and Behçet's disease (for the treatment of oral ulcers).
Dosage form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC: L04AA32
-
It is used in adults for the treatment of active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and Behçet's disease (for the treatment of oral ulcers).
Dosage form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC: L04AA32
-
The medicine is used in adult patients with active psoriatic arthritis, moderate to severe chronic plaque psoriasis, and in Behçet's disease (for the treatment of oral ulcers).
Dosage form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC: L04AA32